Cited by 202Sleep and related disordersObstructive Sleep Apnea ResearchDiabetes Management and Research

Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature

Open access
Schipper, Samantha B. J., Van Veen, Maaike M., Elders, Petra J. M., van Straten, Annemieke, Van Der Werf, Ysbrand D., Knutson, Kristen L., Rutters, Femke·2021·Diabetologia

Abstract

Abstract Sleep disorders are linked to development of type 2 diabetes and increase the risk of developing diabetes complications. Treating sleep disorders might therefore play an important role in the prevention of diabetes progression. However, the detection and treatment of sleep disorders are not part of standardised care for people with type 2 diabetes. To highlight the importance of sleep disorders in people with type 2 diabetes, we provide a review of the literature on the prevalence of sleep disorders in type 2 diabetes and the association between sleep disorders and health outcomes, such as glycaemic control, microvascular and macrovascular complications, depression, mortality and quality of life. Additionally, we examine the extent to which treating sleep disorders in people with type 2 diabetes improves these health outcomes. We performed a literature search in PubMed from inception until January 2021, using search terms for sleep disorders, type 2 diabetes, prevalence, treatment and health outcomes. Both observational and experimental studies were included in the review. We found that insomnia (39% [95% CI 34, 44]), obstructive sleep apnoea (55–86%) and restless legs syndrome (8–45%) were more prevalent in people with type 2 diabetes, compared with the general population. No studies reported prevalence rates for circadian rhythm sleep–wake disorders, central disorders of hypersomnolence or parasomnias. Additionally, several cross-sectional and prospective studies showed that sleep disorders negatively affect health outcomes in at least one diabetes domain, especially glycaemic control. For example, insomnia is associated with increased HbA1c levels (2.51 mmol/mol [95% CI 1.1, 4.4]; 0.23% [95% CI 0.1, 0.4]). Finally, randomised controlled trials that investigate the effect of treating sleep disorders in people with type 2 diabetes are scarce, based on a small number of participants and sometimes inconclusive. Conventional therapies such as weight loss, sleep education and cognitive behavioural therapy seem to be effective in improving sleep and health outcomes in people with type 2 diabetes. We conclude that sleep disorders are highly prevalent in people with type 2 diabetes, negatively affecting health outcomes. Since treatment of the sleep disorder could prevent diabetes progression, efforts should be made to diagnose and treat sleep disorders in type 2 diabetes in order to ultimately improve health and therefore quality of life. Graphical abstract

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-021-05541-0

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Diabetes mellitus and hyperthyroidism may contribute to sleep disturbances through mechanisms such as nocturia, autonomic dysregulation, or association with comorbidities such as restless legs syndrome/Willis-Ekbom disease and obstructive sleep apnea.

    “Diabetes mellitus and hyperthyroidism may contribute to sleep disturbances through mechanisms such as nocturia, autonomic dysregulation, or association with comorbidities such as restless legs syndrome/Willis-Ekbom disease and obstructive sleep apnea.”

    From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [57]

    The “Possible mechanisms, clinical implications and future research” section says type 2 diabetes and associated conditions, including nocturia and increased sympathetic activity, may contribute to sleep disorders. It also reports higher prevalence of restless legs syndrome and obstructive sleep apnoea in people with type 2 diabetes. The paper does not address hyperthyroidism as a contributor to sleep disturbances. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Sleep disturbances are associated with less engagement in diabetes self-management among people with type 1 and type 2 diabetes.

    “Moreover, sleep disturbances are associated with less engagement in diabetes self-management and may interfere with the achievement of glycemic targets among people with type 1 and type 2 diabetes (434-439).”
  • Sleep disturbances may interfere with the achievement of glycemic targets among people with type 1 and type 2 diabetes.

    “Moreover, sleep disturbances are associated with less engagement in diabetes self-management and may interfere with the achievement of glycemic targets among people with type 1 and type 2 diabetes (434-439).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schipper, S. B. J., Van Veen, M. M., Elders, P. J. M., van Straten, A., Van Der Werf, Y. D., Knutson, K. L., & Rutters, F.
Affiliations
  • Amsterdam Public Health (NL)
  • University of Chicago (US)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Rutters, Femke
Venue
Diabetologia
Published
2021-08-16
Volume
64
Issue
11
Pages
2367-2377
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3195762401
Cited by
202
References
77
Citations by year
2026: 37 · 2025: 61 · 2024: 41 · 2023: 44 · 2022: 19
FWCI
4.26
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG059291)
  • National Heart, Lung, and Blood Institute (R01HL141881)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
sleep disorders, type 2 diabetes, insomnia, obstructive sleep apnea, restless legs syndrome, glycemic control, HbA1c, diabetes complications, microvascular complications, macrovascular complications, depression, mortality, quality of life, cognitive behavioral therapy, sleep education, weight loss, diabetes progression
MeSH terms
Cross-Sectional Studies, Diabetes Mellitus, Type 2, Health Status Indicators, Humans, Sleep Initiation and Maintenance Disorders, Prospective Studies, Restless Legs Syndrome, Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm, Sleep Apnea, Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review